Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2007
10/11/2007WO2007112913A2 Benzimidazole derivatives
10/11/2007WO2007112832A1 Use of valproic acid for the topical treatment of mild to moderate acne vulgaris
10/11/2007WO2007112828A1 Associations of xanthogenates and cyclodextrins, and their use
10/11/2007WO2007112754A2 Pharmaceutical compositions comprising anti-mirna antisense oligonucleotides
10/11/2007WO2007112753A2 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
10/11/2007WO2007112669A1 Dicyclooctane derivates, preparation processes and medical uses thereof
10/11/2007WO2007112648A1 The medicinal compositions comprising triptolide derivatives and its dosage form and application
10/11/2007WO2007112619A1 Oseltamivir phosphate granule and preparation mehtod thereof
10/11/2007WO2007112574A1 Extended release composition of venlafaxine
10/11/2007WO2007112573A1 Nitrate esters of sterols/stanols and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
10/11/2007WO2007112572A1 Sterols/stanols chemically linked to nitrogen releasing compounds and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
10/11/2007WO2007112536A1 Increased phytosterol content through overexpression of an acyl-coa sterol acyltransferase
10/11/2007WO2007112524A1 Dietary supplement for healing or regressing symptoms of gastroesophageal reflux disease, gastritis and ulcers
10/11/2007WO2007112475A1 A method of treating cancer and/or cellular proliferative conditions and agents targeting hyaluronan anabolism useful for same
10/11/2007WO2007098387A3 Antihypertensive therapy
10/11/2007WO2007098128A3 Phenylephrine-containing liquid formulations
10/11/2007WO2007096072A3 New pyridin-3-amine derivatives
10/11/2007WO2007095618A3 Benzo-fused heterocycle sulfamide derivatives for the treatment of migraine
10/11/2007WO2007095609A3 Use of benzo-heteroaryl sulfamide derivatives for the treatment of mania and bipolar disorder
10/11/2007WO2007095561A3 Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
10/11/2007WO2007092888A3 Hcv ns5b inhibitors
10/11/2007WO2007092213A3 Inhibitors of e1 activating enzyme
10/11/2007WO2007090844A8 Trihydrochloride forms of a dihydropteridinone derivative and processes for preparation
10/11/2007WO2007089571A8 Method of treating chronic kidney disease
10/11/2007WO2007089335A3 Multicyclic amino acid derivatives and methods of their use
10/11/2007WO2007088050A3 Method of treatment for muscular dystrophy
10/11/2007WO2007085567A3 Synergistic compositions for treating hiv
10/11/2007WO2007084135A9 Inhibitors of checkpoint kinases
10/11/2007WO2007078271A3 Lansoprazole orally disintegrating tablets
10/11/2007WO2007077541A3 Cosmetic composition comprising glaucine and its use
10/11/2007WO2007075901A3 Quinolin- 4 - one derivatives as modulators of abc transporters
10/11/2007WO2007072179A3 Histone deacetylase inhibitors for enhancing activity of antifungal agents
10/11/2007WO2007071967A3 Substituted phenol derivatives as analgesics
10/11/2007WO2007071875A3 Use of ceramides for depigmenting the skin
10/11/2007WO2007071313A3 Combination of anticholinergics, glucocorticoids, beta2-ag0nists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases
10/11/2007WO2007070632A3 Abuse resistant transmucosal drug delivery device
10/11/2007WO2007067807B1 Tetracyclines for treating ocular diseases and disorders
10/11/2007WO2007061554A3 Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries
10/11/2007WO2007060627A3 Use of macrolide derivatives for treating acne
10/11/2007WO2007057858A3 Compositions useful for prevention and treatment of common cold and influenza-like symptoms
10/11/2007WO2007057790A3 Substituted bicyclic pyrimidone derivatives
10/11/2007WO2007057714A3 Pharmaceutical compositions comprising methotrexate
10/11/2007WO2007054750A3 Process for the preparation of olanzapine
10/11/2007WO2007048042A3 Small molecule inhibitors of hiv-1 capsid assembly
10/11/2007WO2007047625A3 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/11/2007WO2007046966A3 Methods for the treatment of influenza
10/11/2007WO2007042465A3 Combinati0n of nilotinib with farnesyl transferase inhibitors
10/11/2007WO2007042111A3 Use of estradiol valerate combined with dienogest for oral therapy of dysfunctional uterine bleeding in the form of oral contraceptives
10/11/2007WO2007041479A3 Pharmaceutical compositions
10/11/2007WO2007039155A3 Use of soluble guanylate cyclase activators for treating acute and chronic lung diseases
10/11/2007WO2007039122A3 Solid orally administerable pharmaceutical dosage forms with rapid active principle release
10/11/2007WO2007038802A3 Methods for preparing core-shell composites having cross-linked shells and core-shell composites resulting therefrom
10/11/2007WO2007038571A3 Prolyl hydroxylase antagonists
10/11/2007WO2007038387A3 Compounds and methods for the treatment of viruses and cancer
10/11/2007WO2007036363A3 Compositions containing butyric acid ester of carbohydrates and carbohydrate polyols
10/11/2007WO2007035395A3 Therapeutic compositions comprising chorionic gonadotropins and hmg coa reductase inhibitors
10/11/2007WO2007033231A3 Novel lysine salts of 4-((phenoxyalkyl) thio)-phenoxyacetic acid derivatives
10/11/2007WO2007030800A3 Acute treatment of social phobia
10/11/2007WO2007030580A3 Neuroprotectants
10/11/2007WO2007028145A3 Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
10/11/2007WO2007024993A3 Fused aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/11/2007WO2007017505A3 Treatment of metabolic diseases
10/11/2007WO2007016679A3 Combination immediate release controlled release levodopa and carbidopa dosage forms
10/11/2007WO2007005603A3 Novel hydroxamic acid-containing amino acid derivatives
10/11/2007WO2007005469A3 Method of enhanced benzoyl peroxide application
10/11/2007WO2007002720A3 An impurity of anastrozole intermediate, and uses thereof
10/11/2007WO2007002458A3 Non-nucleoside reverse transcriptase inhibitors
10/11/2007WO2006132647A3 Antimicrobial copolymers and uses thereof
10/11/2007WO2006118914A3 Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition
10/11/2007WO2006108948A3 Novel isoindole derivatives, compositions containing same, preparation thereof and pharmaceutical uses thereof in particular as inhibitors of chaperone protein hsp90 activities
10/11/2007WO2006094763A8 3,4,5-substituted piperidine compounds
10/11/2007WO2006086381A3 Hepatitis c virus inhibitors
10/11/2007WO2006083945A8 Rnai-mediated inhibition of ocular targets
10/11/2007WO2006064277A8 Silicon compounds and their use
10/11/2007WO2006031555A3 Compositions and methods for treatment of skin discoloration
10/11/2007WO2005115394A3 Prenyl-electrostatic switch, and methods of use
10/11/2007WO2005097131A3 Intermittent dosing regimen for the treatment of overweight with mtp-inhibitors
10/11/2007WO2005055736A8 Compositions of marine botanicals to provide nutrition to aging and environmentally damaged skin
10/11/2007WO2005051326A3 Treatment of a condition in a mammal with administration of compounds and methods of use thereof
10/11/2007WO2003084461A3 Novel anti-bacterial compositions
10/11/2007WO2000072801A3 Alpha v integrin receptor antagonists
10/11/2007US20070240236 O-glycans in the treatment of inflammatory bowel disease and cancers
10/11/2007US20070239116 Systems and methods for administering a medical regimen
10/11/2007US20070238875 Heterocyclic compounds
10/11/2007US20070238866 Methods of producing c-aryl glucoside sglt2 inhibitors
10/11/2007US20070238793 Structural carotenoid analogs or derivatives for the modulation of systemic and/or target organ redox status
10/11/2007US20070238792 Use of agomelatine in obtaining medicaments intended for the treatment of Generalized Anxiety Disorder
10/11/2007US20070238791 Methods and pharmaceutical compositions for treatment of anti-estrogen resistant breast cancer using RXR modulators
10/11/2007US20070238790 Methods and compositions for making and using polymorphs of cinacalcet
10/11/2007US20070238789 Prednisolone acetate compositions
10/11/2007US20070238788 Treatment of renal disorders, diabetic nephropathy and dyslipidemias
10/11/2007US20070238787 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
10/11/2007US20070238786 Pharmaceutical Methods, Dosing Regimes And Dosage Forms For The Treatment Of Alzheimer's Disease
10/11/2007US20070238785 Use of an anti-atherothrombotic compound in obtaining medicaments intended for the treatment of vascular disorders
10/11/2007US20070238784 such as 1,8-dihydroxy-3-methoxy-6-methylanthracene-9,10-dione, used for the treatment gastrointestinal disorders such as inflammatory bowel disease
10/11/2007US20070238783 Beta-benzyloxyaspartate derivatives with amino group on benzene ring
10/11/2007US20070238782 Treating diabetic foot ulcer by topically administering a compound selected from (R)-1-(5,8-dihydroxy-1,4-dioxo-1,4-dihydronaphthalen-2-yl)-4-methylpent-3-enyl acetate and 5,8-dihydroxy-2-(1-hydroxy-4-methylpent-3-enyl)naphthalene-1,4-dione
10/11/2007US20070238781 Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
10/11/2007US20070238779 Carisoprodol articles and methods
10/11/2007US20070238778 Method for producing enantiomeric form of 2,3-diaminopropionic acid derivatives
1 ... 3547 3548 3549 3550 3551 3552 3553 3554 3555 3556 3557 3558 3559 3560 3561 3562 3563 3564 3565 3566 3567 ... 7860